Cargando…
Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift
On November 30, 2022, OpenAI enabled public access to ChatGPT, a next-generation artificial intelligence with a highly sophisticated ability to write, solve coding issues, and answer questions. This communication draws attention to the prospect that ChatGPT and its successors will become important v...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013638/ https://www.ncbi.nlm.nih.gov/pubmed/36808255 http://dx.doi.org/10.1093/jncics/pkad010 |
_version_ | 1784906824404697088 |
---|---|
author | Hopkins, Ashley M Logan, Jessica M Kichenadasse, Ganessan Sorich, Michael J |
author_facet | Hopkins, Ashley M Logan, Jessica M Kichenadasse, Ganessan Sorich, Michael J |
author_sort | Hopkins, Ashley M |
collection | PubMed |
description | On November 30, 2022, OpenAI enabled public access to ChatGPT, a next-generation artificial intelligence with a highly sophisticated ability to write, solve coding issues, and answer questions. This communication draws attention to the prospect that ChatGPT and its successors will become important virtual assistants to patients and health-care providers. In our assessments, ranging from answering basic fact-based questions to responding to complex clinical questions, ChatGPT demonstrated a remarkable ability to formulate interpretable responses, which appeared to minimize the likelihood of alarm compared with Google’s feature snippet. Arguably, the ChatGPT use case presents an urgent need for regulators and health-care professionals to be involved in developing standards for minimum quality and to raise patient awareness of current limitations of emerging artificial intelligence assistants. This commentary aims to raise awareness at the tipping point of a paradigm shift. |
format | Online Article Text |
id | pubmed-10013638 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-100136382023-03-15 Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift Hopkins, Ashley M Logan, Jessica M Kichenadasse, Ganessan Sorich, Michael J JNCI Cancer Spectr Commentary On November 30, 2022, OpenAI enabled public access to ChatGPT, a next-generation artificial intelligence with a highly sophisticated ability to write, solve coding issues, and answer questions. This communication draws attention to the prospect that ChatGPT and its successors will become important virtual assistants to patients and health-care providers. In our assessments, ranging from answering basic fact-based questions to responding to complex clinical questions, ChatGPT demonstrated a remarkable ability to formulate interpretable responses, which appeared to minimize the likelihood of alarm compared with Google’s feature snippet. Arguably, the ChatGPT use case presents an urgent need for regulators and health-care professionals to be involved in developing standards for minimum quality and to raise patient awareness of current limitations of emerging artificial intelligence assistants. This commentary aims to raise awareness at the tipping point of a paradigm shift. Oxford University Press 2023-02-21 /pmc/articles/PMC10013638/ /pubmed/36808255 http://dx.doi.org/10.1093/jncics/pkad010 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Commentary Hopkins, Ashley M Logan, Jessica M Kichenadasse, Ganessan Sorich, Michael J Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift |
title | Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift |
title_full | Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift |
title_fullStr | Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift |
title_full_unstemmed | Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift |
title_short | Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift |
title_sort | artificial intelligence chatbots will revolutionize how cancer patients access information: chatgpt represents a paradigm-shift |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013638/ https://www.ncbi.nlm.nih.gov/pubmed/36808255 http://dx.doi.org/10.1093/jncics/pkad010 |
work_keys_str_mv | AT hopkinsashleym artificialintelligencechatbotswillrevolutionizehowcancerpatientsaccessinformationchatgptrepresentsaparadigmshift AT loganjessicam artificialintelligencechatbotswillrevolutionizehowcancerpatientsaccessinformationchatgptrepresentsaparadigmshift AT kichenadasseganessan artificialintelligencechatbotswillrevolutionizehowcancerpatientsaccessinformationchatgptrepresentsaparadigmshift AT sorichmichaelj artificialintelligencechatbotswillrevolutionizehowcancerpatientsaccessinformationchatgptrepresentsaparadigmshift |